The Strange Case of Jekyll and Hyde: Parallels Between Neural Stem Cells and Glioblastoma-Initiating Cells

被引:8
|
作者
Bakhshinyan, David [1 ]
Savage, Neil [1 ]
Salim, Sabra Khalid [1 ]
Venugopal, Chitra [2 ]
Singh, Sheila K. [1 ,2 ]
机构
[1] McMaster Univ, Fac Hlth Sci, Dept Biochem & Biomed Sci, Hamilton, ON, Canada
[2] McMaster Univ, Fac Hlth Sci, Dept Surg, Hamilton, ON, Canada
来源
FRONTIERS IN ONCOLOGY | 2021年 / 10卷
关键词
glioblastoma stem cells; neural stem cells; neurogenic niche; tumor microenvironment; tumor metabolism; ACUTE MYELOID-LEUKEMIA; PATIENT-DERIVED GLIOBLASTOMA; INTEGRATED GENOMIC ANALYSIS; TERT PROMOTER MUTATIONS; HIGH-GRADE GLIOMAS; ADULT HUMAN BRAIN; SUBVENTRICULAR ZONE; SELF-RENEWAL; EXTRACELLULAR-MATRIX; GENE-EXPRESSION;
D O I
10.3389/fonc.2020.603738
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During embryonic development, radial glial precursor cells give rise to neural lineages, and a small proportion persist in the adult mammalian brain to contribute to long-term neuroplasticity. Neural stem cells (NSCs) reside in two neurogenic niches of the adult brain, the hippocampus and the subventricular zone (SVZ). NSCs in the SVZ are endowed with the defining stem cell properties of self-renewal and multipotent differentiation, which are maintained by intrinsic cellular programs, and extrinsic cellular and niche-specific interactions. In glioblastoma, the most aggressive primary malignant brain cancer, a subpopulation of cells termed glioblastoma stem cells (GSCs) exhibit similar stem-like properties. While there is an extensive overlap between NSCs and GSCs in function, distinct genetic profiles, transcriptional programs, and external environmental cues influence their divergent behavior. This review highlights the similarities and differences between GSCs and SVZ NSCs in terms of their gene expression, regulatory molecular pathways, niche organization, metabolic programs, and current therapies designed to exploit these differences.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Identification of signals regulating the fate of glioblastoma-initiating cells
    Wurdak, Heiko
    Romero, Angelica
    Lorger, Mihaela
    Zhu, Shoutian
    Watson, James
    Santidrian, Antonio
    Chiang, Chih-yuan
    Welch, Genevieve
    Tu, Buu
    Orth, Tony
    Steindler, Dennis
    Harsh, Griffith
    Felding-Habermann, Brunhilde
    Miraglia, Loren
    Skirboll, Stephen
    Rines, Daniel
    Schultz, Peter
    CANCER RESEARCH, 2009, 69
  • [2] Glim: A novel marker and target for glioblastoma-initiating cells.
    Kondo, Toru
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 205 - 205
  • [3] HIGH-RESOLUTION NMR SPECTROSCOPY OF GLIOBLASTOMA-INITIATING CELLS
    Ramm, Paul
    Vollmann-Zwerenz, Arabel
    Beier, Christoph
    Aigner, Ludwig
    Bogdahn, Ulrich
    Kalbitzer, Hans R.
    Hau, Peter
    NEURO-ONCOLOGY, 2010, 12 : 123 - 123
  • [4] Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells
    Malric, Laure
    Monferran, Sylvie
    Delmas, Caroline
    Arnauduc, Florent
    Dahan, Perrine
    Boyrie, Sabrina
    Deshors, Pauline
    Lubrano, Vincent
    Da Mota, Dina Ferreira
    Gilhodes, Julia
    Filleron, Thomas
    Siegfried, Aurore
    Evrard, Solene
    Kowalski-Chauvel, Aline
    Moyal, Elizabeth Cohen-Jonathan
    Toulas, Christine
    Lemarie, Anthony
    MOLECULAR CANCER RESEARCH, 2019, 17 (02) : 384 - 397
  • [5] Mesenchymal stem cell-like properties of CD133+ glioblastoma-initiating cells
    Pavon, Lorena Favaro
    Sibov, Tatiana Tais
    de Oliveira, Daniela Mara
    Marti, Luciana C.
    Cabral, Francisco Romero
    de Souza, Jean Gabriel
    Boufleur, Pamela
    Malheiros, Suzana M. F.
    de Paiva Neto, Manuel A.
    da Cruz, Edgard Ferreira
    Chudzinski-Tavassi, Ana Marisa
    Cavalheiro, Sergio
    ONCOTARGET, 2016, 7 (26) : 40546 - 40557
  • [6] Stem Cells and Cancer Stem Cells: The Jekyll and Hyde Scenario and Their Implications in Stem Cell Therapy
    Zaman, Wan Safwani Wan Kamarul
    Nurul, Asma Abdullah
    Nordin, Fazlina
    BIOMEDICINES, 2021, 9 (09)
  • [7] PARP inhibitors and IR join forces to strike glioblastoma-initiating cells
    N Lugli
    I Kamileri
    T D Halazonetis
    Cell Death & Differentiation, 2014, 21 : 192 - 193
  • [8] A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells
    Wolpert, Fabian
    Tritschler, Isabel
    Steinle, Alexander
    Weller, Michael
    Eisele, Guenter
    NEURO-ONCOLOGY, 2014, 16 (03) : 382 - 391
  • [9] PARP inhibitors and IR join forces to strike glioblastoma-initiating cells
    Lugli, N.
    Kamileri, I.
    Halazonetis, T. D.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (02): : 192 - 193
  • [10] Discovery of a new pyrimidine synthesis inhibitor eradicating glioblastoma-initiating cells
    Echizenya, Smile
    Ishii, Yukiko
    Kitazawa, Satoshi
    Tanaka, Tadashi
    Matsuda, Shun
    Watanabe, Eriko
    Umekawa, Masao
    Terasaka, Shunsuke
    Houkin, Kiyohiro
    Hatta, Tomohisa
    Natsume, Tohru
    Maeda, Yoshimasa
    Watanabe, Shin-ichi
    Hagiwara, Shinji
    Kondo, Toru
    NEURO-ONCOLOGY, 2020, 22 (02) : 229 - 239